News

QDOSE to be part of commercial partnership with Telix

We are proud to announce that the dosimetry software QDOSE® designed by us and our development partner Quantinm AB will now become part of a commercial partnership with Telix. Telix intends to integrate the platform into its therapeutic radiopharmaceutical programmes...

read more

Visiting SNMMI 2024 in Toronto

Summer 2024 is coming up and as every year we are returning to the SNMMI 2024 in Toronto, Canada on June 8-11. Our two General Managers, Dr. Andreas Kluge and Andreas Fintelmann, and the CEO of ABX-CRO INC, Moritz Kallerhoff, will be there again accompanied by our...

read more

Visiting Chile for TWC 2024

This year we will start our conference activities in Santiago, Chile for the 7th Theranostics World Congress. From March 22 to 24 you can find us at booth #A06 and talk with Dr. Andreas Kluge and Andreas Fintelmann, our General Managers, about how ABX-CRO can help you...

read more

Phase 2 study for improvement of prostate cancer diagnosis

Prostate cancer awareness month may already be over, but men's health remains an important topic. We are therefore most pleased to announce that ABX-CRO was chosen to collaborate with Curasight in a phase 2 study to improve the diagnosis of prostate cancer. The...

read more

TRP EU in December 2023

We are happy to announce that our last conference this year will be the Targeted Radiopharmaceuticals Summit Europe. Come and find us in Berlin from 5 to 7 December. Join us for our talks: “Using multiple legislations to optimise clinical trial conduct (EU & USA)”...

read more

ABX-CRO announces the opening of ABX-CRO India at EANM’23

Indian scientists led the way to today´s nuclear medicine: Suresh Srivastava: Fundamental 99mTechnetium generator technology and labelling Nagichettiar Satyamurthy: 18F-labelling methodology & molecular pharmacology Shrikant Deshpande: DOTA as chelator for...

read more

ABX-CRO at EANM’23

On to the next congress – from September 9-13 we will head to Vienna to be part of the 36th Annual Congress of the European Association of Nuclear Medicine – the EANM'23. The EANM industrial exhibition gives an extensive overview of the latest achievements in...

read more

TRP US 2023 and AGRR

After returning from a successful SNMMI in Chicago, we are now excited to participate in the second Targeted Radipharmaceuticals Summit US - the TRP US. Moritz Kallerhoff, ABX-CRO INC.'s Chief Executive Officer, will be on site for us in Boston from July 25-27 to...

read more

ABX-CRO goes SNMMI 2023

Once again we will be attending the premier event for education, science, research and networking in nuclear medicine and molecular imaging - SNMMI 2023 - you will find us in Chicago, Illinois, June 24-27, Booth #3082. We have been an almost annual attendee of this...

read more

Andreas Fintelmann visiting iSRS23

Our General Manager Andreas Fintelmann is heading to Honolulu in May to attend the 25th iSRS conference. From 22-25.5. there will be an outstanding collection of plenaries and workshops. A great opportunity to reactivate old connections and make new ones while in the...

read more